MedPath

Acacia catechu to increase salivary flow in Dry Mouth Patients

Not Applicable
Conditions
Health Condition 1: R682- Dry mouth, unspecified
Registration Number
CTRI/2020/03/023776
Lead Sponsor
PreethiA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Men and women diagnosed with head and neck carcinoma who undergoing radiotherapy as a treatment modality.

2.Age 20 to 70 years.

3.Post radiotherapy patients with a salivary flow rate <= 0.2 ml / min

Exclusion Criteria

-Patients using xerostomia â?? relieving medications (Pilocarpine and Cevimeline) or therapies for Xerostomia (Mouthwash, Gum, and Toothpaste for Xerostomia).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Salivary flow rate. <br/ ><br>Anti-microbial activity against Streptococcus mutans and Lactobacillus acidophillusTimepoint: salivary flow rate and antimicrobial activity assessment checked as following intervals: <br/ ><br> <br/ ><br>1. baseline value <br/ ><br>2. mid intervention period at 4 weeks <br/ ><br>3. post intervention period - 8 weeks
Secondary Outcome Measures
NameTimeMethod
QUALITY OF LIFE - QUESTIONNAIRETimepoint: 0 WEEKS AND AT 8 WEEKS
© Copyright 2025. All Rights Reserved by MedPath